Completed PHASE1 INTERVENTIONAL 1-arm NCT00474669

A Phase I Study of Intraperitoneal Hyperthermic Docetaxel (IP)

A Phase I Study of Intraperitoneal Hyperthermic Docetaxel at the Time of Second Look Surgery Following Front-Line Normothermic Intraperitoneal and Intravenous Cisplatin/Paclitaxel for Patients With Stage II and III Ovarian Carcinoma

Sponsor: James Graham Brown Cancer Center

Conditions Ovarian Carcinoma

Interventions docetaxel

Updated 7 times since 2017 Last updated: Jan 5, 2018 Started: Jun 30, 2007 Primary completion: Dec 31, 2009 Completion: Dec 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Ovarian Carcinoma and is currently completed. James Graham Brown Cancer Center leads this study, which shows 7 recorded versions since 2007 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2018 — Jun 2018 [monthly]

Completed PHASE1

▶ Show 2 earlier versions

Feb 2017 — Jan 2018 [monthly]

Completed PHASE1
Jan 2017 — Feb 2017 [monthly]

Completed PHASE1

First recorded

Jun 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

James Graham Brown Cancer Center
University of Louisville

Data source: University of Louisville

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Louisville, United States